CDH2 and neoplasm: Considering the critical role of the EMT process in tumor metastasis, we examined the expression of epithelial markers (E-cadherin and claudin-1) and mesenchymal markers (N-cadherin and vimentin) to address whether DDX17 is required for the EMT progression of CRC.